New Zealand vs Niger: Access to anti-retroviral drugs, female
New Zealand
80.0%
in 2024
Niger
79.0%
in 2024
New Zealand rank
57th
Niger rank
59th
Access to anti-retroviral drugs, female over time
- New Zealand
- Niger
How they compare
New Zealand currently reports 80.0% against 79.0% in Niger, a difference of 1.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was New Zealand ahead.
New Zealand ranks 57th and Niger ranks 59th of 141 countries.
Across the 3 decades both report, New Zealand averaged higher in 2 and Niger in 1.
Head to head by decade
| Decade | New Zealand | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 47.5% | 5.0% | 42.5% | New Zealand |
| 2010s | 64.6% | 54.5% | 10.1% | New Zealand |
| 2020s | 73.8% | 83.2% | 9.4% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, New Zealand or Niger?
- New Zealand, at 80.0% against 79.0% in Niger as of 2024.
- What is the difference in access to anti-retroviral drugs, female between New Zealand and Niger?
- 1.0%, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Niger?
- 25 years are reported by both, from 2000 to 2024.
- How do New Zealand and Niger rank globally for access to anti-retroviral drugs, female?
- New Zealand ranks 57th and Niger ranks 59th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.